Physician profile
Joseph E Walsh
NPI 1124649843
$903.49
in general payments reported to CMS, 2019-2025
21 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $333 · 2024: $242 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $239.29 | 2022-2025 | Phasix Mesh |
| Otsuka America Pharmaceutical, INC. | $135.19 | 2023-2024 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $103.90 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $73.99 | 2023-2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $36.27 | 2022-2023 | Ligasure |
| Exact Sciences Corporation | $35.15 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbvie INC. | $32.53 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $30.15 | 2025 | Voquezna |
| Aimmune Therapeutics, INC. | $21.58 | 2024 | |
| Glaxosmithkline, LLC. | $19.58 | 2023 | Trelegy Ellipta, Shingrix |
| Kci USA, INC. | $19.39 | 2023 | Prevena, Activ.A.C. |
| Corcept Therapeutics | $17.13 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.93 | 2025 | Xifaxan |
| Lundbeck LLC | $16.36 | 2025 | Vyepti |
| Impel Pharmaceuticals INC. | $16.28 | 2023 | Trudhesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.83 | 2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.80 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $15.42 | 2022 | |
| Hologic Sales and Service, LLC | $15.08 | 2025 | Thinprep 2000 Processor, Aptima |
| Amgen INC. | $14.33 | 2023 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $13.31 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.